Stockscreener 앱 받기
19.52
2.04%
0.39
전일 마감가:
$19.13
열려 있는:
$19.34
하루 거래량:
1.26M
Relative Volume:
0.87
시가총액:
$2.39B
수익:
$460.48M
순이익/손실:
$142.80M
주가수익비율:
16.54
EPS:
1.18
순현금흐름:
$221.79M
1주 성능:
-1.31%
1개월 성능:
-2.11%
6개월 성능:
-22.39%
1년 성능:
-2.16%
1일 변동 폭
$19.15
$19.55
1주일 범위
$19.05
$20.25
52주 변동 폭
$19.05
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
명칭
Catalyst Pharmaceuticals Inc
전화
(305) 529-2522
주소
355 ALHAMBRA CIRCLE, CORAL GABLES
CPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
19.52 | 2.34B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 개시 | Robert W. Baird | Outperform |
| 2024-11-18 | 개시 | Stephens | Overweight |
| 2024-03-14 | 개시 | Citigroup | Buy |
| 2024-03-07 | 개시 | BofA Securities | Buy |
| 2023-12-21 | 개시 | Oppenheimer | Outperform |
| 2022-08-24 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-09-07 | 재개 | Piper Jaffray | Overweight |
| 2016-10-05 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2016-04-26 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2014-09-30 | 재확인 | ROTH Capital | Buy |
| 2014-09-16 | 재확인 | ROTH Capital | Buy |
| 2014-09-15 | 재확인 | H.C. Wainwright | Buy |
| 2013-10-21 | 재확인 | Aegis Capital | Buy |
| 2013-09-24 | 개시 | Maxim Group | Buy |
| 2013-09-06 | 재확인 | Aegis Capital | Buy |
| 2013-04-18 | 개시 | Aegis Capital | Buy |
| 2012-08-27 | 업그레이드 | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| 2009-10-01 | 업그레이드 | Merriman | Sell → Neutral |
| 2009-05-29 | 다운그레이드 | Hapoalim | Neutral → Underperform |
| 2009-05-29 | 다운그레이드 | Merriman Curhan Ford | Buy → Sell |
| 2008-12-15 | 개시 | Merriman Curhan Ford | Buy |
| 2007-11-28 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-01-31 | 개시 | Stifel Nicolaus | Buy |
| 2007-01-05 | 개시 | First Albany | Buy |
모두보기
Catalyst Pharmaceuticals Inc 주식(CPRX)의 최신 뉴스
Catalyst Pharmaceuticals Hits 52-Week Low at $19.05 Amid Market Volatility - Markets Mojo
Catalyst Pharmaceuticals stock hits 52-week low at $19.13 By Investing.com - Investing.com South Africa
Catalyst Pharmaceuticals (NASDAQ:CPRX) Sets New 1-Year LowTime to Sell? - MarketBeat
Catalyst Pharmaceuticals stock hits 52-week low at $19.13 - Investing.com
Catalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Redhawk Wealth Advisors Inc. Acquires 13,407 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - sharewise.com
Strs Ohio Purchases Shares of 41,000 Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Weekly Trades: What is the next catalyst for Lipella Pharmaceuticals IncLong Setup & Daily Chart Pattern Signals - khodrobank.com
Swedbank AB Makes New $14.94 Million Investment in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Downgrade Watch: Does Catalyst Pharmaceuticals Inc align with a passive investing strategyBreakout Watch & Verified Momentum Watchlists - khodrobank.com
Risk Analysis: What is the next catalyst for Petros Pharmaceuticals Inc2025 Biggest Moves & High Conviction Trade Alerts - khodrobank.com
Richard P Slaughter Associates Inc Sells 54,614 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Wesbanco Bank Inc. Buys 37,000 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
IPO Launch: Is Catalyst Pharmaceuticals Inc likely to announce a buybackWeekly Risk Report & Safe Swing Trade Setups - خودرو بانک
Loss Report: How does Catalyst Pharmaceuticals Inc. perform in inflationary periods2025 Momentum Check & Real-Time Buy Signal Alerts - خودرو بانک
Sell Signal: Is Catalyst Pharmaceuticals Inc likely to announce a buybackPrice Action & Long-Term Investment Growth Plans - خودرو بانک
First Week of November 21st Options Trading For Catalyst Pharmaceuticals (CPRX) - Nasdaq
Catalyst Pharmaceuticals (NASDAQ:CPRX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Woodline Partners LP Has $5.01 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Aug Fed Impact: What is the next catalyst for CASI Pharmaceuticals IncEarnings Growth Report & Reliable Breakout Stock Forecasts - khodrobank.com
Buyback Watch: What is Catalyst Pharmaceuticals Inc.’s TAM (Total Addressable Market)2025 Key Highlights & Community Consensus Picks - خودرو بانک
Aug PreEarnings: Can Catalyst Pharmaceuticals Inc stock outperform in a bear market2025 AllTime Highs & Real-Time Chart Pattern Alerts - khodrobank.com
AQR Capital Management LLC Sells 31,501 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Rally Mode: Is Catalyst Pharmaceuticals Inc a top pick in the sectorEarnings Growth Report & Free Fast Entry Momentum Trade Alerts - خودرو بانک
What is the next catalyst for CASI Pharmaceuticals IncMarket Trend Review & Technical Pattern Recognition Alerts - خودرو بانک
Chart Watch: Is Catalyst Pharmaceuticals Inc currently under institutional pressureJuly 2025 Action & Daily Profit Focused Screening - خودرو بانک
Ideas Watch: Will Catalyst Pharmaceuticals Inc benefit from government policyWeekly Risk Report & Stepwise Trade Execution Plans - خودرو بانک
Fred Alger Management LLC Buys Shares of 51,402 Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Insider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Sells 30,000 Shares of Stock - MarketBeat
Catalyst Pharmaceutical (CPRX) is a Top-Ranked Value Stock: Should You Buy? - sharewise.com
Is Despegarcom Corp a cyclical or defensive stockJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - خودرو بانک
Signal Recap: Should I trade or invest in Catalyst Pharmaceuticals IncGold Moves & Weekly Top Performers Watchlists - خودرو بانک
Technical Analysis: How is Catalyst Pharmaceuticals Inc. managing supply chain issues2025 Performance Recap & Community Trade Idea Sharing Platform - خودرو بانک
Visualizing Catalyst Pharmaceuticals Inc. stock with heatmaps2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Top chart patterns to watch in Catalyst Pharmaceuticals Inc.Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Catalyst Pharmaceuticals Inc (CPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Catalyst Pharmaceuticals Inc 주식 (CPRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Elsbernd Brian | Chief Compliance/Legal Officer |
Sep 08 '25 |
Sale |
20.30 |
30,000 |
609,000 |
271,039 |
3.41%
0.81%
자본화:
|
볼륨(24시간):